PRO-DEX, INC. Inventory, Work in Process, Gross
PRO-DEX, INC. (PDEX) had Inventory, Work in Process, Gross of $7.70 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-09-03
- 2026-06-30: Inventory, Work in Process, Gross $7.70M.
- 2026-03-31: Inventory, Work in Process, Gross $8.13M.
- 2025-12-31: Inventory, Work in Process, Gross $6.81M.
- 2025-09-30: Inventory, Work in Process, Gross $6.90M.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2026-06-30 | $7.70M 10-K · filed 2026-09-03 | |
| 2026-03-31 | $8.13M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $6.81M 10-Q · filed 2026-01-29 | |
| 2025-09-30 | $6.90M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $7.42M 10-K · filed 2026-09-03 | |
| 2025-03-31 | $9.33M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $7.30M 10-Q · filed 2025-01-30 | |
| 2024-09-30 | $5.73M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $5.10M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $3.94M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $3.90M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $4.52M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $3.69M 10-K · filed 2024-09-05 | |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.62M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $4.10M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $3.46M 10-K · filed 2023-10-13 | |
| 2022-03-31 | $2.52M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.77M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $2.83M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.22M 10-K · filed 2022-09-08 | |
| 2021-03-31 | $1.90M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.33M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $2.33M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.34M 10-K · filed 2021-09-09 | |
| 2020-03-31 | $2.57M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.39M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $2.56M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.51M 10-K · filed 2020-09-10 | |
| 2019-03-31 | $1.43M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.46M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $1.39M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $974.00K 10-K · filed 2019-09-12 | |
| 2018-03-31 | $1.22M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $894.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $960.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $746.00K 10-K · filed 2018-09-13 | $747.00K 10-K · filed 2017-09-14 |
| 2017-03-31 | $957.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $813.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $972.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $818.00K 10-K · filed 2017-09-14 | |
| 2016-03-31 | $949.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $924.00K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $1.01M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.03M 10-K · filed 2016-09-15 | |
| 2015-03-31 | $934.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $725.00K 10-Q · filed 2015-02-10 | |
| 2014-09-30 | $750.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $525.00K 10-K · filed 2015-09-17 | |
| 2014-03-31 | $700.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $499.00K 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $521.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $572.00K 10-K · filed 2014-09-18 | |
| 2013-03-31 | $986.00K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $657.00K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $879.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $579.00K 10-K · filed 2013-09-27 | |
| 2011-06-30 | $746.00K 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |